rs35194418

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_176824.3(BBS7):​c.186C>T​(p.Pro62Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00122 in 1,613,080 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P62P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0062 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00071 ( 5 hom. )

Consequence

BBS7
NM_176824.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.51

Publications

1 publications found
Variant links:
Genes affected
BBS7 (HGNC:18758): (Bardet-Biedl syndrome 7) This gene encodes one of eight proteins that form the BBSome complex containing BBS1, BBS2, BBS4, BBS5, BBS7, BBS8, BBS9 and BBIP10. The BBSome complex is believed to recruit Rab8(GTP) to the primary cilium and promote ciliogenesis. The BBSome complex assembly is mediated by a complex composed of three chaperonin-like BBS proteins (BBS6, BBS10, and BBS12) and CCT/TRiC family chaperonins. Mutations in this gene are implicated in Bardet-Biedl syndrome, a genetic disorder whose symptoms include obesity, retinal degeneration, polydactyly and nephropathy; however, mutations in this gene and the BBS8 gene are thought to play a minor role and mutations in chaperonin-like BBS genes are found to be a major contributor to disease development in a multiethnic Bardet-Biedl syndrome patient population. Two transcript variants encoding distinct isoforms have been identified for this gene.[provided by RefSeq, Oct 2014]
BBS7 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 4-121861659-G-A is Benign according to our data. Variant chr4-121861659-G-A is described in ClinVar as Benign. ClinVar VariationId is 262920.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.51 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00617 (936/151742) while in subpopulation AFR AF = 0.0203 (839/41352). AF 95% confidence interval is 0.0192. There are 7 homozygotes in GnomAd4. There are 450 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BBS7NM_176824.3 linkc.186C>T p.Pro62Pro synonymous_variant Exon 4 of 19 ENST00000264499.9 NP_789794.1 Q8IWZ6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BBS7ENST00000264499.9 linkc.186C>T p.Pro62Pro synonymous_variant Exon 4 of 19 1 NM_176824.3 ENSP00000264499.4 Q8IWZ6-1
BBS7ENST00000506636.1 linkc.186C>T p.Pro62Pro synonymous_variant Exon 4 of 18 1 ENSP00000423626.1 Q8IWZ6-2
BBS7ENST00000502444.1 linkn.360C>T non_coding_transcript_exon_variant Exon 4 of 4 2
BBS7ENST00000505692.1 linkn.21C>T non_coding_transcript_exon_variant Exon 1 of 2 2

Frequencies

GnomAD3 genomes
AF:
0.00616
AC:
934
AN:
151624
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0203
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00309
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000952
Gnomad MID
AF:
0.00321
Gnomad NFE
AF:
0.000427
Gnomad OTH
AF:
0.00865
GnomAD2 exomes
AF:
0.00179
AC:
450
AN:
251110
AF XY:
0.00140
show subpopulations
Gnomad AFR exome
AF:
0.0215
Gnomad AMR exome
AF:
0.00159
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000264
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.000711
AC:
1039
AN:
1461338
Hom.:
5
Cov.:
31
AF XY:
0.000604
AC XY:
439
AN XY:
726962
show subpopulations
African (AFR)
AF:
0.0182
AC:
610
AN:
33460
American (AMR)
AF:
0.00204
AC:
91
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26112
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39666
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86236
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53378
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5768
European-Non Finnish (NFE)
AF:
0.000182
AC:
202
AN:
1111654
Other (OTH)
AF:
0.00192
AC:
116
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
50
101
151
202
252
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00617
AC:
936
AN:
151742
Hom.:
7
Cov.:
32
AF XY:
0.00607
AC XY:
450
AN XY:
74120
show subpopulations
African (AFR)
AF:
0.0203
AC:
839
AN:
41352
American (AMR)
AF:
0.00309
AC:
47
AN:
15228
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4806
European-Finnish (FIN)
AF:
0.0000952
AC:
1
AN:
10500
Middle Eastern (MID)
AF:
0.00345
AC:
1
AN:
290
European-Non Finnish (NFE)
AF:
0.000427
AC:
29
AN:
67932
Other (OTH)
AF:
0.00856
AC:
18
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
44
87
131
174
218
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00256
Hom.:
2
Bravo
AF:
0.00692
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000296

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bardet-Biedl syndrome 1 Benign:1
Jun 28, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Bardet-Biedl syndrome Benign:1
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.43
DANN
Benign
0.57
PhyloP100
-1.5
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35194418; hg19: chr4-122782814; API